TAFAMIDIS and CARDIAC FAILURE

Overview

CARDIAC FAILURE is the #4 most commonly reported adverse reaction for TAFAMIDIS, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 544 FDA adverse event reports linking TAFAMIDIS to CARDIAC FAILURE. This represents approximately 3.1% of all 17,433 adverse event reports for this drug.

Patients taking TAFAMIDIS who experience cardiac failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE is moderately reported among TAFAMIDIS users, representing a notable but not dominant share of adverse events.

Other Side Effects of TAFAMIDIS

In addition to cardiac failure, the following adverse reactions have been reported for TAFAMIDIS:

• DEATH — 2,785 reports
• DYSPNOEA — 712 reports
• OFF LABEL USE — 649 reports
• FATIGUE — 526 reports
• FALL — 422 reports
• ATRIAL FIBRILLATION — 349 reports
• MALAISE — 331 reports
• DIZZINESS — 328 reports
• ASTHENIA — 307 reports
• HYPOACUSIS — 303 reports

Other Drugs Associated with CARDIAC FAILURE

The following drugs have also been linked to cardiac failure in FDA adverse event reports:

Does TAFAMIDIS cause CARDIAC FAILURE?

CARDIAC FAILURE has been reported as an adverse event in 544 FDA reports for TAFAMIDIS. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE with TAFAMIDIS?

CARDIAC FAILURE accounts for approximately 3.1% of all adverse event reports for TAFAMIDIS, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE while taking TAFAMIDIS?

If you experience cardiac failure while taking TAFAMIDIS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages